Directory › International › NEU
ASX: NEU
Neuren Pharmaceuticals Limited
Pharmaceuticals, Biotechnology & Life Sciences · New Zealand · $1.7B
Biopharmaceutical company with a focus on neurological conditions.
| ASX code | NEU |
|---|---|
| Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Market capitalisation | $1.7B |
| Listed on ASX | 03/02/2005 |
| Registered office | At the offices of Lowndes Jordan, Level 15, PWC Tower, 188 Quay Street, AUCKLAND, ., NEW ZEALAND, 1141 |
| State | New Zealand (cross-listed) |
| Phone | +61 3 9092 0480 |
| Fax | +64 9 361 7981 |
| Website | http://www.neurenpharma.com ↗ |
Share registry
Shareholders contact the share registry (not the company) for holdings, dividends and address changes.
| Registry | MUFG CORPORATE MARKETS (AU) LIMITED |
|---|---|
| Phone | 1300 554 474 |
| Address | Tower 4, 727 Collins Street, DOCKLANDS, VIC, AUSTRALIA, 3008 |